-
Breaking News: Innovative Biopharmaceutical 'Aibei Gesiting α Injection' by Evive Biotech Receives ...
In a significant milestone for the pharmaceutical industry, Evive Biotech has achieved a major breakthrough with its innovative biopharmaceutical prod...
2024-03-25 15:40 -
Revolutionary Arrival of ADC: Will AbbVie Alter Its Fate?
In the realm of ADC (Antibody-Drug Conjugate) development, a groundbreaking achievement has taken place, raising the question of whether AbbVie is abo...
2024-03-25 15:38 -
Breakthrough Study Reveals the Promising Efficacy of AkesoBio's 'PD-1/VEGF Bispecific Antibody' Yiwu...
A groundbreaking study presented at the highly anticipated 2024 European Lung Cancer Congress (ELCC) has unveiled encouraging results regarding the ef...
2024-03-25 15:36 -
Revolutionary Breakthrough: Hengrui Pharmaceuticals Unveils Groundbreaking Findings on Carrelizumab ...
Hengrui Pharmaceuticals has recently unveiled the latest data from their innovative drug, Carrelizumab.
2024-03-25 15:33 -
Breaking News: Stemirna Therapeutics Halts mRNA Cancer Vaccine Development
Stemirna Therapeutics, a leading biotechnology company, has announced the suspension of its groundbreaking mRNA personalized cancer vaccine, SW1115C3....
2024-03-25 15:30 -
Explosive Surge of 3.7 Billion CNY in Performance for Leading Dual-Targeted Therapy Company!
In an unprecedented achievement, a prominent biotech company has reported a staggering surge in performance, with revenues skyrocketing by 3.7 billion...
2024-03-20 14:55 -
Astonishing Acquisition: AstraZeneca Acquires Fusion Pharmaceuticals for $2.4 Billion in a Landmark ...
In a groundbreaking deal, global pharmaceutical giant AstraZeneca has announced its acquisition of Fusion Pharmaceuticals, a leading nuclear medicine ...
2024-03-20 14:49 -
Qyuns Therapeutics Makes Groundbreaking Debut on Hong Kong Stock Exchange as the First 'Self-Immunit...
Qyuns Therapeutics, commonly known as the "Self-Immunity Pioneer," commenced trading on the Hong Kong Stock Exchange today.
2024-03-20 14:48 -
Breakthrough: Everest Medicines's Nefecon® Receives HSA Approval for New Drug Launch
Everest Medicines announced that Nefecon®, their groundbreaking drug for the treatment of primary IgA nephropathy in adults at risk of disease progre...
2024-03-20 14:45 -
Biotech Power Struggle: Founder Ousted from the Game
In a dramatic turn of events, the biotech industry has witnessed a power struggle that resulted in the ousting of a prominent founder.
2024-03-20 14:42
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products
Related Producers
